US2019117706A1PendingUtilityA1

Feed additive composition

Assignee: DUPONT NUTRITION BIOSCI APSPriority: Aug 3, 2012Filed: Oct 2, 2018Published: Apr 25, 2019
Est. expiryAug 3, 2032(~6 yrs left)· nominal 20-yr term from priority
C12Y 302/01008C12Y 302/01021A23K 50/60A23K 10/18A23K 10/16A23Y 2220/00A23K 50/75A61K 38/47A23K 50/30A61K 35/742A61K 35/747A23K 20/189C12N 9/2402A23V 2400/11
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A feed additive composition comprising a direct fed microbial (DFM), in combination with a xylanase (e.g. endo-1,4-β-d-xylanase) and a β-glucanase (and optionally a further fibre degrading enzyme), wherein the DFM is selected from the group consisting of an enzyme producing strain; a C5 sugar-fermenting strain; a short-chain fatty acid-producing strain; a fibrolytic, endogenous microflora-promoting strain; or combinations thereof. The DFM may be selected from the group consisting of: Bacillus subtilis AGTP BS3BP5, Bacillus subtilis AGTP BS442, B. subtilis AGTP BS521, B. subtilis AGTP BS918, Bacillus subtilis AGTP BS1013, B. subtilis AGTP BS1069, B. subtilis AGTP 944, B. pumilus AGTP BS 1068 or B. pumilus KX11-1, Enterococcus faecium ID7, Propionibacterium acidipropionici P169, Lactobacillus rhamnosus CNCM-I-3698, Lactobacillus farciminis CNCM-I-3699, a strain having all the characteristics thereof, any derivative or variant thereof, and combinations thereof and the further fibre degrading enzyme may be selected from the group consisting of a cellobiohydrolase (E.C. 3.2.1.176 and E.C. 3.2.1.91), a β-glucosidase (E.C. 3.2.1.21), a β-xylosidase (E.C. 3.2.1.37), a feruloyl esterase (E.C. 3.1.1.73), an α-arabinofuranosidase (E.C. 3.2.1.55), a pectinase (e.g. an endopolygalacturonase (E.C. 3.2.1.15), an exopolygalacturonase (E.C. 3.2.1.67) or a pectate lyase (E.C. 4.2.2.2)), or combinations thereof.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method for improving the performance of a subject or for improving digestibility of a raw material in a feed, or for improving nitrogen retention, or for improving feed conversion ratio (FCR), or for improving weight gain in a subject, or for improving feed efficiency in a subject, or for shifting the fermentation process in the subject's gastrointestinal tract towards the production of butyric acid and/or propionic acid, the method comprising administering a direct fed microbial (DFM) to the subject, in combination with a xylanase and a β-glucanase, wherein the DFM is selected from the group consisting of an enzyme producing strain; a C5 sugar-fermenting strain; a short-chain fatty acid-producing strain; a fibrolytic, endogenous microflora-promoting strain; and combinations thereof. 
     
     
         3 . The method of  claim 2 , wherein the DFM is an enzyme producing strain. 
     
     
         4 . The method of  claim 2 , wherein the DFM is a C5 sugar-fermenting strain. 
     
     
         5 . The method of  claim 2 , wherein the DFM is a short-chain fatty acid-producing strain. 
     
     
         6 . The method of  claim 2 , wherein the DFM is a fibrolytic, endogenous microflora-promoting strain. 
     
     
         7 . The method of  claim 2 , wherein the DFM is at least one strain of bacterium selected from the group consisting of the following genera:  Bacillus, Enterococcus, Lactobacillus, Propionibacterium  and combinations thereof. 
     
     
         8 . The method of  claim 2 , wherein the DFM is at least one strain selected from the  Bacillus  genus. 
     
     
         9 . The method of  claim 2 , wherein the DFM is selected from the group consisting of:  Bacillus subtilis  AGTP BS3BP5,  Bacillus subtilis  AGTP BS442,  Bacillus subtilis  AGTP BS521,  Bacillus subtilis  AGTP BS918,  Bacillus subtilis  AGTP BS1013,  Bacillus subtilis  AGTP BS1069,  Bacillus subtilis  AGTP 944 , B. pumilus  AGTP BS 1068 or  B. pumilus  KX11-1,  Enterococcus faecium  ID7,  Propionibacterium acidipropionici  P169,  Lactobacillus rhamnosus  CNCM-I-3698,  Lactobacillus farciminis  CNCM-I-3699, and combinations thereof. 
     
     
         10 . The method of  claim 2 , wherein the DFM is a viable bacterium. 
     
     
         11 . The method of  claim 2 , wherein the direct fed microbial is in the form of an endospore. 
     
     
         12 . The method of  claim 2 , wherein the xylanase is an endo-1,4-β-d-xylanase. 
     
     
         13 . (canceled) 
     
     
         14 . The method of  claim 2 , wherein the method comprises administering to a subject a direct fed microbial (DFM), in combination with a xylanase and a β-glucanase and a further fibre degrading enzyme. 
     
     
         15 . The method of  claim 14 , wherein the further fibre degrading enzyme is selected from the group consisting of a cellobiohydrolase (E.C. 3.2.1.176 and E.C. 3.2.1.91), a β-glucosidase (E.C. 3.2.1.21), a β-xylosidase (E.C. 3.2.1.37), a feruloyl esterase (E.C. 3.1.1.73), an α-arabinofuranosidase (E.C. 3.2.1.55), a pectinase (e.g. an endopolygalacturonase (E.C. 3.2.1.15), an exopolygalacturonase (E.C. 3.2.1.67) or a pectate lyase (E.C. 4.2.2.2)), or combinations thereof. 
     
     
         16 . The method of  claim 15 , wherein the further fibre degrading enzyme is selected from the group consisting of a cellobiohydrolase (E.C. 3.2.1.176 and E.C. 3.2.1.91), a β-glucosidase (E.C. 3.2.1.21) or combinations thereof. 
     
     
         17 . The method of  claim 2 , further comprising administering at least one vitamin and/or at least one mineral to the subject. 
     
     
         18 - 25 . (canceled) 
     
     
         26 . The method of  claim 2 , wherein the DFM is selected from the group consisting of  Bacillus subtilis, B. licheniformis, B. amyloliquefaciens , and  B. pumilus.

Join the waitlist — get patent alerts

Track US2019117706A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.